Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
Tudor MoisoiuMihnea Paul DragomirStefania D IancuSimon SchallenbergGiovanni BiroloGiulio FerreroDan BurgheleaAndrei StefancuRamona G CozanEmilia LicareteAlessandra AllioneGiuseppe MatulloGheorghita IacobZoltán BálintRadu I BadeaAlessio NaccaratiDavid HorstBarbara PardiniNicolae LeopoldFlorin ElecPublished in: Molecular medicine (Cambridge, Mass.) (2022)
miRNA profiling synergizes with SERS profiling for point-of-care diagnostic and molecular stratification of BC. By combining the two liquid biopsy methods, a clinically relevant tool that can aid BC patients is envisaged.